- Home
- MCK vs TRI Comparison
MCK vs TRI Comparison
Compare MCK & TRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCK
- TRI
- Stock Information
- Founded
- MCK 1833
- TRI 1851
- Country
- MCK United States
- TRI Canada
- Employees
- MCK N/A
- TRI N/A
- Industry
- MCK Other Pharmaceuticals
- TRI
- Sector
- MCK Health Care
- TRI
- Exchange
- MCK Nasdaq
- TRI Nasdaq
- Market Cap
- MCK 88.8B
- TRI 87.9B
- IPO Year
- MCK N/A
- TRI N/A
- Fundamental
- Price
- MCK $719.31
- TRI $198.65
- Analyst Decision
- MCK Strong Buy
- TRI Hold
- Analyst Count
- MCK 12
- TRI 6
- Target Price
- MCK $691.42
- TRI $185.33
- AVG Volume (30 Days)
- MCK 1.1M
- TRI 565.1K
- Earning Date
- MCK 05-08-2025
- TRI 05-01-2025
- Dividend Yield
- MCK 0.39%
- TRI 1.20%
- EPS Growth
- MCK 14.87
- TRI N/A
- EPS
- MCK 25.72
- TRI 4.78
- Revenue
- MCK $359,051,000,000.00
- TRI $7,273,000,000.00
- Revenue This Year
- MCK $14.20
- TRI $4.11
- Revenue Next Year
- MCK $7.86
- TRI $7.98
- P/E Ratio
- MCK $27.97
- TRI $41.38
- Revenue Growth
- MCK 16.22
- TRI 4.78
- 52 Week Low
- MCK $464.42
- TRI $150.01
- 52 Week High
- MCK $731.00
- TRI $198.77
- Technical
- Relative Strength Index (RSI)
- MCK 57.59
- TRI 73.43
- Support Level
- MCK $704.99
- TRI $191.52
- Resistance Level
- MCK $721.52
- TRI $196.27
- Average True Range (ATR)
- MCK 13.27
- TRI 3.00
- MACD
- MCK -0.40
- TRI 0.31
- Stochastic Oscillator
- MCK 82.52
- TRI 99.26
About MCK McKesson Corporation
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
About TRI Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008. In 2021, Thomson Reuters completed the sale of Refinitiv to LSE Group. Thomson Reuters' three largest segments are its legal professionals, Tax and accounting, and corporates segments. Legal professionals is about 42% of the firm's revenue and 47% of the firm's adjusted EBITDA. Tax and accounting makes up about 20%-25% of the firm's revenue and EBITDA. Corporates, which consists of legal professionals and tax and accounting products sold to corporations, also makes up about 20%-25% of the firm's revenue and EBITDA. Thomson Reuters' smaller segments include its Reuters news business and global print business.